Major pharmaceutical transporter in Latin America will nearly double freighter capacity by 2023
In an effort to grow its freighter fleet, LATAM Group, a major transporter of pharmaceutical products in Latin America, plans to add 10 Boeing 767-300 Boeing Converted Freighters over the next three years. The first aircraft will be expected to begin operations in December.
LATAM’s freighter fleet growth plan originally consisted of four firm conversion orders with Boeing, along with another four conversion options. Two months after the initial announcement, LATAM has exercised the four options, eight planes and the conversion of two additional Boeing 767-300ERs—this brings the fleet size to up to 21 freighters by the end of 2023.
Growing from 11 to 21 freighter planes will enable LATAM's cargo subsidiaries to expand and reinforce their capacity to, from and within South America. The first eight airplanes have been assigned to markets that are crucial for key customer segments, the company notes.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Boosting Patient Adherence: The Power of Clinical Support Programs
October 3rd 2024In this podcast, we speak with Amanda Scholz, UBC Senior Clinical Program Manager, MHA, BSN, RN as we discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.